![System.Func`1[System.String]](/siteassets/images/z-mckesson-logosicons/mckesson-biopharma.png)
3 in 4
3 in 4 community oncologists in mid-to-large size practices are eager to give clinical trial design input.
Advancing Community Oncology Report
Explore the 2025 report to see how collaboration between biopharma and community oncology is transforming patient care, driving innovation and shaping the future of cancer treatment.
The Next Frontier for Biopharma Innovation
It’s an unprecedented time in oncology as treatment advancements accelerate and industry-wide shifts make it more possible than ever for patients to receive care closer to home. That’s where community oncology practices come in, offering more options for patients to gain access to high-quality, integrated, state-of-the-art care inside their existing support networks.
The Advancing Community Oncology Report offers an analysis of the current landscape and future outlook of community-based cancer care, uncovering top opportunities for collaboration among providers, biopharma and industry leaders to advance patient care.
Inside the Report
Get exclusive survey insights from 200+ community oncologists and administrators across the country alongside perspectives from leading oncologists and McKesson leaders on topics such as:
- expanding clinical trial access
- accelerating precision medicine adoption
- supporting the evolving needs of patients
- readiness for the future of cancer care
- adapting to the rapidly changing landscape of community oncology
The Data at a Glance
Discover insights that reveal how community practices are navigating rapid change and where collaboration with biopharma can make the greatest impact.
95%
95% of community oncologists believe personalized medicine will significantly improve survival.
77%
77% of administrators see a demand for more patient education support for younger survivors.
80%
80% of community oncologists expect AI-enabled features to have a major impact on care delivery this decade.
Voices Shaping Community Oncology
In the report, you’ll hear directly from voices shaping the future of community oncology — including community oncologists, administrators, key opinion leaders, McKesson leaders and more.
As healthcare shifts toward more patient-centered models, community oncology is key to building a sustainable future for cancer care.
President, Oncology and Multispecialty, McKesson
Hope Close to Home
Experience the impact of community-based clinical trials — and how access to cutting-edge treatment close to home made all the difference in Mike's life.
We know what’s possible with this next era of cancer care. Now it’s up to all of us to make it accessible for every patient, everywhere.
Texas Oncology
Oncology & Multispecialty Solutions
Our oncology ecosystem connects biopharma innovators, providers and technology partners to accelerate drug development, expand clinical trial participation and deliver advanced therapies to patients in community settings. Our integrated solutions help translate scientific breakthroughs into real-world impact for patients and practices nationwide.
Learn More